C049 | PEGASPARGASE ADMINISTRATION AND TOLERABILITY IN PATIENTS AGED 55 YEARS OR OLDER WITH ACUTE LYMPHOBLASTIC LEUKEMIA TREATED WITH THE LAL1913 PROGRAM. A SUBANALYSIS OF THE CAMPUS ALL-LAL1913 STUDY.

Introduction: The adoption of pediatric-inspired regimens for adult Ph-negative ALL improved the prognosis of this disease. However, the feasibility of these programs in older pts is limited due to the increased incidence of therapy-related AE, especially those related to asparaginase. Very few rea...

Full description

Bibliographic Details

Published in:	Haematologica
Main Authors:	D. Lazzarotto, A.M. Testi, M. Fanin, F. Mosna, S. Chiaretti, C. Papayannidis, A. Curti, M. Piccini, N. Fracchiolla, M. Fumagalli, P. Zappasodi, S. Imbergamo, P. Minetto, F. Guolo, F. Lussana, M. Cerrano, F. Forghieri, M. Leoncin, M. Olivi, M. Lunghi, S. Trappolini, C. Mazzone, M. Defina, L. Aprile, C. Pasciolla, M. Ciccone, E. Mauro, A. Mulè, F. Grimaldi, B. Cambò, L. Santoro, M. Delia, V. Mancini, A. Cignetti, R. Fanin, M. Bonifacio, M. Dargenio, F. Ferrara, G. Pizzolo, R. Foà, A. Candoni
Format:	Article
Language:	English
Published:	Ferrata Storti Foundation 2025-09-01
Online Access:	https://haematologica.org/article/view/12813